Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPLID: Phosphatidylcholine paste in liver diseases
NCT02517385Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of phosphatidylcholine in acute liver failure (ALF), chronic liver disease (CLD), non-alcoholic fatty liver disease (NAFLD), viral hepatitis, sponsored by Sanofi. Started Aug 2015; status: completed.
02
Drugs
phosphatidylcholine
03
Conditions
acute liver failure (ALF)chronic liver disease (CLD)non-alcoholic fatty liver disease (NAFLD)viral hepatitis
Beyond the preview
Go deeper on NCT02517385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517385.